In the series, the “A Crisis in European Equities,” the Financial Times explores why some of Europe's most promising companies are fleeing to America's capital market. We believe it doesn’t have to be an either-or decision. There is a cost-effective and hassle-free alternative: the OTC Markets.

A decade or so ago, listing in the US, the largest stock market in the world, was a costly and complex endeavor for non-US issuers. Not so much anymore, if you consider the benefits and much lower costs of trading on the OTC markets. With name brand megacaps by the likes of Dannon, Roche, Deutsche Telekom, Heineken, Imperial Brands, Marks & Spencer and BNP Paribas, OTC Markets Group has been actively growing its roster.

Investors in the US, though, are not like investors in your home market. They demand greater clarity, transparency, and communication. Along with higher expectations, investors need relevant data and information in order to make informed decisions about historical and future operating performance. Feedback mechanisms are essential to foster this 2-way communication between investors and management.